Skip to main content
Gut logoLink to Gut
. 1996 Apr;38(4):568–573. doi: 10.1136/gut.38.4.568

Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.

J D Butzner 1, R Parmar 1, C J Bell 1, V Dalal 1
PMCID: PMC1383116  PMID: 8707089

Abstract

BACKGROUND--The short chain fatty acid (SCFA) butyrate provides energy for colonocytes, stimulates colonic fluid and electrolyte absorption and is recognised as an effective treatment for multiple types of colitis. AIM--To examine the impact of butyrate enema therapy on the clinical course, severity of inflammation, and SCFA stimulated Na+ absorption in a chronic experimental colitis. METHODS--Distal colitis was induced in rats with a trinitrobenzenesulphonic acid (TNBS) enema. Five days after induction, rats were divided into groups to receive: no treatment, saline enemas, or 100 mM Na-butyrate enemas daily. On day 24, colonic damage score and tissue myeloperoxidase (MPO) activity were evaluated. Colon was mounted in Ussing chambers and Na+ transport and electrical activities were measured during a basal period and after stimulation with 25 mM butyrate. RESULTS--In the untreated and the saline enema treated TNBS groups, diarrhoea and extensive colonic damage were seen, associated with increased tissue MPO activities and absent butyrate stimulated Na+ absorption. In contrast, in the butyrate enema treated TNBS group, diarrhoea ceased, colonic damage score improved, and tissue MPO activity as well as butyrate stimulated Na+ absorption recovered to control values. CONCLUSION--Butyrate enema therapy stimulated colonic repair, as evidenced by clinical recovery, decreased inflammation, and restoration of SCFA stimulated electrolyte absorption.

Full text

PDF
568

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartram H. P., Scheppach W., Schmid H., Hofmann A., Dusel G., Richter F., Richter A., Kasper H. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res. 1993 Jul 15;53(14):3283–3288. [PubMed] [Google Scholar]
  2. Bell C. J., Gall D. G., Wallace J. L. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol. 1995 Apr;268(4 Pt 1):G622–G630. doi: 10.1152/ajpgi.1995.268.4.G622. [DOI] [PubMed] [Google Scholar]
  3. Bergman E. N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990 Apr;70(2):567–590. doi: 10.1152/physrev.1990.70.2.567. [DOI] [PubMed] [Google Scholar]
  4. Binder H. J., Mehta P. Short-chain fatty acids stimulate active sodium and chloride absorption in vitro in the rat distal colon. Gastroenterology. 1989 Apr;96(4):989–996. doi: 10.1016/0016-5085(89)91614-4. [DOI] [PubMed] [Google Scholar]
  5. Breuer R. I., Buto S. K., Christ M. L., Bean J., Vernia P., Paoluzi P., Di Paolo M. C., Caprilli R. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci. 1991 Feb;36(2):185–187. doi: 10.1007/BF01300754. [DOI] [PubMed] [Google Scholar]
  6. Butzner J. D., Meddings J. B., Dalal V. Inhibition of short-chain fatty acid absorption and Na+ absorption during acute colitis in the rabbit. Gastroenterology. 1994 May;106(5):1190–1198. doi: 10.1016/0016-5085(94)90009-4. [DOI] [PubMed] [Google Scholar]
  7. Chapman M. A., Grahn M. F., Boyle M. A., Hutton M., Rogers J., Williams N. S. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut. 1994 Jan;35(1):73–76. doi: 10.1136/gut.35.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clausen M. R., Mortensen P. B. Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology. 1994 Feb;106(2):423–432. doi: 10.1016/0016-5085(94)90601-7. [DOI] [PubMed] [Google Scholar]
  9. D'Argenio G., Cosenza V., Sorrentini I., De Ritis F., Gatto A., Delle Cave M., D'Armiento F. P., Mazzacca G. Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. Gastroenterology. 1994 Feb;106(2):399–404. doi: 10.1016/0016-5085(94)90598-3. [DOI] [PubMed] [Google Scholar]
  10. Fleming S. E., Arce D. S. Volatile fatty acids: their production, absorption, utilization, and roles in human health. Clin Gastroenterol. 1986 Oct;15(4):787–814. [PubMed] [Google Scholar]
  11. Harig J. M., Soergel K. H., Komorowski R. A., Wood C. M. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989 Jan 5;320(1):23–28. doi: 10.1056/NEJM198901053200105. [DOI] [PubMed] [Google Scholar]
  12. Hove H., Holtug K., Jeppesen P. B., Mortensen P. B. Butyrate absorption and lactate secretion in ulcerative colitis. Dis Colon Rectum. 1995 May;38(5):519–525. doi: 10.1007/BF02148853. [DOI] [PubMed] [Google Scholar]
  13. Kripke S. A., Fox A. D., Berman J. M., Settle R. G., Rombeau J. L. Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. JPEN J Parenter Enteral Nutr. 1989 Mar-Apr;13(2):109–116. doi: 10.1177/0148607189013002109. [DOI] [PubMed] [Google Scholar]
  14. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989 Mar;96(3):795–803. [PubMed] [Google Scholar]
  15. Ramakrishna B. S., Roediger W. E. Bacterial short chain fatty acids: their role in gastrointestinal disease. Dig Dis. 1990;8(6):337–345. doi: 10.1159/000171266. [DOI] [PubMed] [Google Scholar]
  16. Roediger W. E., Lawson M. J., Kwok V., Grant A. K., Pannall P. R. Colonic bicarbonate output as a test of disease activity in ulcerative colitis. J Clin Pathol. 1984 Jun;37(6):704–707. doi: 10.1136/jcp.37.6.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Roediger W. E., Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol. 1986 Dec;67(6):773–782. [PMC free article] [PubMed] [Google Scholar]
  18. Roediger W. E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980 Sep;21(9):793–798. doi: 10.1136/gut.21.9.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Roediger W. E. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet. 1980 Oct 4;2(8197):712–715. doi: 10.1016/s0140-6736(80)91934-0. [DOI] [PubMed] [Google Scholar]
  20. Rowe W. A., Lesho M. J., Montrose M. H. Polarized Na+/H+ exchange function is pliable in response to transepithelial gradients of propionate. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6166–6170. doi: 10.1073/pnas.91.13.6166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scheppach W., Bartram P., Richter A., Richter F., Liepold H., Dusel G., Hofstetter G., Rüthlein J., Kasper H. Effect of short-chain fatty acids on the human colonic mucosa in vitro. JPEN J Parenter Enteral Nutr. 1992 Jan-Feb;16(1):43–48. doi: 10.1177/014860719201600143. [DOI] [PubMed] [Google Scholar]
  22. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994 Jan;35(1 Suppl):S35–S38. doi: 10.1136/gut.35.1_suppl.s35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Scheppach W., Sommer H., Kirchner T., Paganelli G. M., Bartram P., Christl S., Richter F., Dusel G., Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992 Jul;103(1):51–56. doi: 10.1016/0016-5085(92)91094-k. [DOI] [PubMed] [Google Scholar]
  24. Senagore A. J., MacKeigan J. M., Scheider M., Ebrom J. S. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum. 1992 Oct;35(10):923–927. doi: 10.1007/BF02253492. [DOI] [PubMed] [Google Scholar]
  25. Steinhart A. H., Brzezinski A., Baker J. P. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol. 1994 Feb;89(2):179–183. [PubMed] [Google Scholar]
  26. Wallace J. L., Keenan C. M., Gale D., Shoupe T. S. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology. 1992 Jan;102(1):18–27. doi: 10.1016/0016-5085(92)91779-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES